bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Neoplasms, Pleural

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Neoplasms, Pleural in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, L; Hong, WK; Khokhar, AR; Lopez-Berestein, G; Lu, C; Perez-Soler, R; Piperdi, B; Ro, JY; Shin, DM; Shin, HJ; Smythe, WR; Swisher, SG; Truong, M; Walsh, GL; Yalamanchili, A	1
Hong, WK; Huber, M; Khokhar, AR; Lee, SJ; Murphy, WK; Perez-Soler, R; Shin, DM; Siddik, ZH	1

Trials

2 trial(s) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Neoplasms, Pleural

Article	Year
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, May-20, Volume: 23, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Carriers; Female; Follow-Up Studies; Humans; Immunohistochemistry; Liposomes; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Pleural Neoplasms; Probability; Risk Assessment; Survival Rate; Thoracoscopy; Treatment Outcome	2005
Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Drug Carriers; Female; Humans; Liposomes; Lung Neoplasms; Male; Mesothelioma; Metabolic Clearance Rate; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Rats	1997

Article

Year

Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, May-20, Volume: 23, Issue:15

Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Carriers; Female; Follow-Up Studies; Humans; Immunohistochemistry; Liposomes; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Pleural Neoplasms; Probability; Risk Assessment; Survival Rate; Thoracoscopy; Treatment Outcome

2005

Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:3

Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Drug Carriers; Female; Humans; Liposomes; Lung Neoplasms; Male; Mesothelioma; Metabolic Clearance Rate; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Rats

1997